Oncovalent Therapeutics Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Oncovalent Therapeutics Inc. - overview
Established
2015
Location
Thousand Oaks, CA, US
Primary Industry
Biotechnology
About
Founded in 2015 and based in California, US, Oncovalent Therapeutics Inc. , formerly known as SUMO Bioscience, Inc. operates as an early-stage small molecule company focused on oncology therapeutics. The company changed its name from SUMO Bioscience, Inc.
to Oncovalent Therapeutics Inc. in 2020.
Current Investors
Corner Ventures
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Pharmaceuticals
Website
www.oncovalent.com
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.